Other
Restructuring, Settlement and Impairment Provisions
Albemarle Restructuring, Settlement and Impairment Provisions increased by 1014.4% to $25.87M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3205.2%, from -$833K to $25.87M.
Analysis
StatementIncome Statement
SectionOther
First reportedQ1 2013
Last reportedQ1 2026May 6, 2026
Metric ID:
other_restructuring_settlement_and_impairment_provisionsHistorical Data
6 periods
| Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|
| Value | $297.47M | $860.86M | -$833K | $4.28M | $2.32M | $25.87M |
| QoQ Change | — | +189.4% | -100.1% | +614.3% | -45.8% | >999% |
| YoY Change | — | — | — | -98.6% | -99.7% | >999% |
Range-$833K – $860.86M
CAGR-85.8%
Avg YoY Growth>999%
Median YoY Growth-98.6%
Frequently Asked Questions
- What is Albemarle's restructuring, settlement and impairment provisions?
- Albemarle (ALB) reported restructuring, settlement and impairment provisions of $25.87M in Q1 2026.
- How has Albemarle's restructuring, settlement and impairment provisions changed year-over-year?
- Albemarle's restructuring, settlement and impairment provisions increased by 3205.2% year-over-year, from -$833K to $25.87M.